Montelukast Sodium
Product Images NDC 68071-2846

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 68071-2846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2846 9)

Pdp (68071 2846 9)
Montelukast Sodium 10mg tablet label from NuCare Pharmaceuticals, Inc., showing a 90 count package. The label includes NDC 68071-2846-9 and states Rx Only. Manufacturer is Unichem Laboratories Ltd. Bardez, Goa, India, with packaging by NuCare Pharmaceuticals, Inc. Orange, CA. Additional details include storage instructions and safety warnings.*
FDA Label Image

Figure 1 (Ecb8c513 E5ee 4501 A240 B2d644615559 01)

Figure 1 (Ecb8c513 E5ee 4501 A240 B2d644615559 01)
A line graph showing the change in height (cm) over weeks on treatment for three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The x-axis represents weeks on treatment from -19 to 56, and the y-axis shows change in height ranging from -3 to 7 cm. Montelukast Sodium and Placebo groups show a steady increase in height over time, while the Beclomethasone group shows a slightly slower increase.*
FDA Label Image

Structure (Ecb8c513 E5ee 4501 A240 B2d644615559 02)

Structure (Ecb8c513 E5ee 4501 A240 B2d644615559 02)
Chemical structure of montelukast sodium, showing its molecular formula and arrangement of atoms including rings, sulfur, chlorine, and sodium components.*
FDA Label Image

Figure 2 (Ecb8c513 E5ee 4501 A240 B2d644615559 03)

Figure 2 (Ecb8c513 E5ee 4501 A240 B2d644615559 03)
A line graph showing mean percent change from baseline over weeks in treatment for montelukast sodium compared to placebo. The x-axis represents weeks of treatment, and the y-axis shows mean percent change. Montelukast sodium shows a higher percent change over time compared to placebo, with a drop during the washout period.*
FDA Label Image

Image (Ecb8c513 E5ee 4501 A240 B2d644615559 907 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.